• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    MeaTech Reports Financial Results for Q1 2022 and Provides Business Update

    5/31/22 8:02:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples
    Get the next $MITC alert in real time by email

    The company continued to develop the technology, R&D and marketing infrastructure necessary to accelerate toward commercialization of cultured meat

    REHOVOT, Israel, May 31, 2022 /PRNewswire/ -- MeaTech 3D Ltd. (NASDAQ:MITC) ("MeaTech") today reported its financial results for Q1 2022 and provided a business update. MeaTech is an international group of deep-tech food companies at the forefront of the cultured meat industry. MeaTech Group uses science and technology to develop high-quality real meat products made from cells rather than farm-raised animals that are delicious, nutritious and safer than conventional meat.

    MeaTech 3D Logo

    Q1 2022 Financial Results Summary

    • Research and development expenses totaled $2.1 million in the three months ending March 31, 2022, compared to $1.1 million in the same period in 2021. The 90% increase is mainly due to the addition of the company's Belgian subsidiary and reflects MeaTech Group's growing investment in research and development as it achieves its milestones and expands its cultured meat technology capabilities.

          
    • General and administrative expenses totaled $2.1 million in the three months ending March 31, 2022, compared to $2.7 million in the same period in 2021. The 23% decrease is driven by lower share-based payment expenses, partially offset by higher D&O insurance expenses in the three months ending March 31, 2022. 

          
    • Marketing expenses totaled $1.1 million in the three months ending March 31, 2022, compared to $0.3 million in the same period in 2021. The 228% increase is mainly the result of share-based payment expenses of $0.5 million, and the company's growing investment in marketing activities.

          
    • Operating loss totaled $5.3 million in the three months ending March 31, 2022, compared to $4.2 million in the same period in 2021. The 26% increase in the operating loss reflects the growing investment of MeaTech Group in research and development as well as marketing activities.

          
    • Total comprehensive loss totaled $5.7 million in the three months ending March 31, 2022, or 40 cents per ordinary share ($4.00 per ADS), compared to $4.4 million, or 40 cents per ordinary share ($4.00 per ADS), in the same period in 2021.

          
    • Cash flow used in operating activities totaled $2.8 million in the three months ending March 31, 2022, compared to $1.2 million in the same period in 2021, reflecting a 137% increase, driven mainly by increased research and development expenditures of MeaTech Group.

          
    • Cash flow used in investment activities totaled $1.0 million in the three months ending March 31, 2022, compared to $5.4 million in the same period in 2021, reflecting an 81% decrease. This resulted mainly from the $4.8 million cash component paid in the acquisition of Peace of Meat in Q1 2021.  

          
    • Cash flow from financing activities was $0.0 million in the three months ending March 31, 2022, compared to $28.2 million in the same period in 2021, during which the company completed its Nasdaq initial public offering. 

          
    • Cash and cash equivalents were $15.3 million on March 31, 2022, compared to $19.2 million at year-end 2021, a decrease of 20%. The decrease was mainly due to the company's ongoing operations.

          
    • Current assets decreased by 23% to $16.9 million on March 31, 2022 from $22.1 million at year-end 2021, as a result of ongoing operations.

          
    • Non-current assets increased by 25% to $23.2 million on March 31, 2022 from $18.5 million at year-end 2021, due mainly to a $4.1 million long-term lease asset of its new premises, offset by the recognition of a lease liability in the same amount in accordance with IFRS requirements.

          
    • Total capital decreased 13% to $32.6 million on March 31, 2022, down from $37.6 million at year-end 2021. The decrease was mainly the result of ongoing operations.

    Arik Kaufman, MeaTech's Chief Executive Officer: "In just the first quarter of 2022, we have shown our rapid pace of progress toward commercialization. Our recent technological and scientific advancements and business activities have put us firmly on a path toward scaling our unique solution for the sustainable production of a wide variety of cultured meat products." 



    Business highlights and developments during Q1 2022

    • Promising results with muscle stem cell differentiation: In February, MeaTech announced the successful development of a novel technology process in which muscle cells are fused into significant muscle fibers that better resemble those in whole cuts of meat. Bovine stem cells were isolated, proliferated in the lab, and differentiated into matured muscle cells with improved muscle fiber density, thickness and length. Based on these improvements, MeaTech has filed a provisional patent application with the USPTO.

        
    • New headquarters to widen R&D activity: In March, the company moved to new, more spacious headquarters with state-of-the-art laboratories in Rehovot, Israel, the epicenter of the country's food-tech sector. The new space allows the company to enhance its cultured meat R&D and 3D bioprinting technology and continue growing the biology and engineering teams with a more expansive lab facility. The new headquarters also features a tasting kitchen.

          
    • Expansion of cultivated meat operation into the US to accelerate go-to-market strategy: In March 2022, MeaTech announced that it will be opening a US office. The new space will include activities in research and development, investor relations, and business development. MeaTech US will be another indication of the company's rapid growth and scaling efforts.

          
    • Peace of Meat pilot plant and R&D facility in Belgium: In March, MeaTech announced that its wholly owned Belgian subsidiary, Peace of Meat, will build an R&D facility and pilot plant in Belgium, with construction expected to commence in 2022. The new facility will expand and accelerate the MeaTech Group's cultured avian technology and R&D capabilities and help propel the company's market entry.

          
    • First-of-its-kind tasting event with Israeli anchor investors: In March, MeaTech hosted a tasting event at the company's headquarters with its Israeli anchor investors, including prominent food industry investors. Guests toured the labs and R&D facilities, observed the company's 3D printing capabilities, and tasted hybrid chicken nuggets made with plant protein combined with cultured chicken developed by Peace of Meat.

          
    • Breakthrough in 3D bioprinting capabilities: In May, MeaTech announced the development of a unique, multi-nozzle 3D bioprinting system for industrial scale production of complex cultured meat products without impacting cell viability. The company plans to offer the technology to third parties via a wholly owned private MeaTech subsidiary as an additional revenue stream and to accelerate commercialization.

          
    • Strategic agreement between Peace of Meat and ENOUGH: In May, Peace of Meat signed a strategic agreement with ENOUGH, a leader in the field of mycoprotein, a fungi-based fermented food ingredient, to accelerate commercialization. This innovative initiative is expected to create game-changing hybrid alternative meat products that better resemble the flavor, aroma, texture, and even nutritional value of conventional meat.

          
    • MeaTech joins the United Nations Global Compact: In May, the company joined the UN Global Compact initiative, committing to ten universally accepted principles in the areas of human rights, labor, environment, and anti-corruption and to act in support of UN goals and issues embodied in the UN's Sustainable Development Goals (SDGs).

     

     

     

    Unaudited Condensed Consolidated Interim Information on the Financial Position











    As of

    March 31





    As of

    March 31





    As of

    December 31









    2022





    2021





    2021









    USD

    thousands





    USD

    thousands





    USD

    thousands





    Current assets











































    Cash and cash equivalents





    15,257







    35,971







    19,176





    Other investment





    151







    144







    154





    Receivables and prepaid expenses





    1,513







    391







    2,782





    Total current assets





    16,921







    36,506







    22,112

































    Non-current assets























































    Restricted deposits





    415







    50







    405





    Other investment





    1,333







    1,259







    1,355





    Right-of-use asset





    4,050







    294







    407





    Intangible assets





    13,196







    9,805







    13,453





    Fixed assets, net





    4,183







    1,797







    2,922

































    Total non-current assets





    23,177







    13,205







    18,542

































    Total Assets





    40,098







    49,711







    40,654

































    Current liabilities























































    Trade payables





    746







    1,357







    382





    Other payables





    2,628







    1,419







    2,239





    Current maturities of lease liabilities





    488







    207







    165

































    Total current liabilities





    3,862







    2,983







    2,786

































    Non-current liabilities























































    Long-term lease liabilities





    3,595







    96







    246

































    Total non-current liabilities





    3,595







    96







    246

































    Equity























































    Share capital and premium on shares





    70,059







    67,243







    69,610





    Capital reserves





    4,026







    2,004







    3,708





    Currency translation differences reserve





    515







    (8)







    1,275





    Accumulated deficit





    (41,959)







    (22,607)







    (36,971)

































    Total Equity





    32,641







    46,632







    37,622





    Total liabilities and Equity





    40,098







    49,711







    40,654





     

     

    Unaudited Condensed Consolidated Interim Information on Comprehensive Income







    3-month

    period ended

    March 31,





    3-month

    period ended

    March 31,





    Year ended

    December 31,







    2022





    2021





    2021







    USD thousands,

    except share data





    USD thousands,

    except share data





    USD thousands,

    except share data























    Research and development expenses





    2,142







    1,126







    7,594



    Marketing expenses





    1,051







    320







    1,628



    General and administrative expenses





    2,118







    2,760







    8,010





























    Operating loss





    5,311







    4,206







    17,232





























    Financing expenses (income), net





    (323)







    (548)







    790





























    Loss for the period





    4,988







    3,658







    18,022





























    Currency translation differences loss (income) that might be

    transferred to profit or loss over ILS





    515







    551







    (1,942)



    Currency translation differences loss that might be transferred to

    profit or loss over EUR





    245







    237







    1,447





























    Total comprehensive loss for the period





    5,748







    4,446







    17,527





























    Loss per ordinary share, no par value (USD)



















































    Basic and diluted loss per share (USD)





    0.040







    0.040







    0.155





























    Weighted-average number of shares outstanding - basic and

    diluted (shares)





    126,235,376







    90,346,518







    115,954,501



     

     

    Unaudited Condensed Consolidated Interim Information on Changes in Equity (Deficit)







    Share and capital

    premium





    Fair value

    of

    financial assets

    reserve





    Transactions

    with related

    parties reserve





    Currency

    translation

    differences

    reserve





    Share-based

    payments

    reserve





    Accumulated

    deficit





    Total







    USD thousands















































    Balance as of January 1, 2022





    69,610







    (334)







    14







    1,275







    4,028







    (36,971)







    37,622





























































    Share-based payments





    -







    -







    -







    -







    714







    -







    714



    Exercise of options





    449































    (396)















    53



    Other comprehensive (loss)





    -







    -







    -







    (760)







    -







    -







    (760)



    Loss for the period





    -







    -







    -







    -







    -







    (4,988)







    (4,988)





























































    Balance as of March 31, 2022





    70,059







    (334)







    14







    515







    4,346







    (41,959)







    32,641





























































    Balance as of January 1, 2021





    30,481







    (334)







    14







    780







    3,639







    (18,949)







    15,631





























































    Share-Based Payment





    -







    -







    -







    -







    1,879







    -







    1,879



    Issuance of shares and warrants, net





    30,357







    -







    -







    -







    -







    -







    30,357



    Exercise of options





    6,405































    (3,194)















    3,211



    Other comprehensive (loss)













    -







    -







    (788)







    -







    -







    (788)



    Loss for the period





    -







    -







    -







    -







    -







    (3,658)







    (3,658)





























































    Balance as of March 31, 2021





    67,243







    (334)







    14







    (8)







    2,324







    (22,607)







    46,632





























































    Balance as of January 1, 2021





    30,481







    (334)







    14







    780







    (3,639)







    (18,949)







    15,631





























































    Share-based payments





    -







    -







    -







    -







    3,965







    -







    3,965



    Issuance of shares and warrants, net





    32,330















































    32,330



    Exercise of options





    6,799







    -







    -







    -







    (3,576)







    -







    3,223



    Other comprehensive income





    -







    -







    -







    495







    -







    -







    495



    Loss for the period





    -







    -







    -







    -







    -







    (18,022)







    (18,022)





























































    Balance as of December 31, 2021





    69,610







    (334)







    14







    1,275







    4,028







    (36,971)







    37,622



     

     

     

    Unaudited Condensed Consolidated Interim Information on Cash Flows







    Three months

    ended March 31,

    2022





    Three months

    ended March 31,

    2021





    Year ended

    December 31,

    2021







    USD thousands





    USD thousands





    USD thousands



    Cash flows – operating activities



















    Net Loss for the period





    (4,988)







    (3,658)







    (18,022)





























    Adjustments:

























    Depreciation and amortization





    382







    109







    680



    Change in fair value of derivative





    -







    (304)







    (316)



    Change in fair value of other investment





    (44)







    (74)







    (193)



    Changes in net foreign exchange expenses





    (340)







    (174)







    1,279



    Share-based payment expenses





    714







    1,879







    3,965





























    Changes in asset and liability items:

























    Decrease (increase) in receivables and prepaid expenses





    1,203







    (50)







    (2,351)



    Increase (decrease) in trade payables





    (382)







    736







    (97)



    Increase in other payables





    615







    336







    1,095



    Net cash (used in) operating activities





    (2,840)







    (1,200)







    (13,960)





























    Cash flows – investment activities

























    Acquisition of fixed assets





    (800)







    (219)







    (1,828)



    Increase of restricted deposit





    (19)







    -







    (337)



    Loan provided





    -







    (367)







    (367)



    Acquisition of subsidiary, net of cash acquired





    (188)







    (4,848)







    (6,808)





























    Net cash used in investing activities





    (1,007)







    (5,434)







    (9,340)





























    Cash flows – financing activities

























    Proceeds from issuance of shares and warrants





    -







    29,281







    29,281



    Issuance costs





    -







    (3,283)







    (3,283)



    Repayment of liability for lease





    (118)







    (58)







    (346)



    Proceeds on account of other investment





    38







    37







    149



    Proceeds from exercise of share options





    53







    3,211







    3,222





























    Net cash provided by (used in) financing activities





    (27)







    29,188







    29,023





























    Increase (decrease) in cash and cash equivalents





    (3,874)







    22,554







    5,723



    Effect of exchange differences on cash and cash equivalents





    (45)







    (137)







    (103)



    Cash and cash equivalents at the beginning of the period:





    19,176







    13,556







    13,556





























    Cash and cash equivalents at end of period





    15,257







    35,973







    19,176





























    Noncash activities

























    Purchase of fixed assets





    756







    222







    57



    Issue of shares and options against intangible asset





    -







    4,359







    6,332



     

     

     

    About MeaTech

    MeaTech is an international group of deep-tech food companies at the forefront of the cultured meat revolution. The company initiated activities in 2019 and is listed on the Nasdaq Capital Market under the ticker "MITC". MeaTech maintains facilities in Rehovot, Israel and Antwerp, Belgium and is in the process of expanding activities to the US. The company believes cultivated meat technologies hold significant potential to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. 

    MeaTech aims to provide an alternative to industrialized animal farming that dramatically reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. With a modular factory design, MeaTech aims to offer a sustainable solution for producing a variety of beef, chicken and pork products, both as raw materials and whole cuts.     

    For more information, please visit: https://meatech3d.com

     

    Forward-Looking Statements 

    This press release contains forward-looking statements concerning MeaTech's business, operations and financial performance and condition as well as plans, objectives, and expectations for MeaTech's business operations and financial performance and condition. Any statements that are not historical facts may be deemed to be forward-looking statements. Forward-looking statements reflect MeaTech's current views with respect to future events and are based on assumptions and subject to known and unknown risks and uncertainties, which change over time, and other factors that may cause MeaTech's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and are typically identified with words such as "may," "could," "should," "will," "would," "believe," "anticipate," "estimate," "expect," "aim," "intend," "plan" or words or phases of similar meaning and include, without limitation, MeaTech's expectations regarding the success of its cultured meat manufacturing technologies it is developing, which will require significant additional work before MeaTech can potentially launch commercial sales; MeaTech's research and development activities associated with technologies for cultured meat manufacturing, including three-dimensional meat production, which involves a lengthy and complex process; MeaTech's ability to obtain and enforce its intellectual property rights and to operate its business without infringing, misappropriating, or otherwise violating the intellectual property rights and proprietary technology of third parties; and other risks and uncertainties, including those identified in MeaTech's Annual Report on Form 20-F for the fiscal year ended December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2022. New risks and uncertainties may emerge from time to time, and it is not possible for MeaTech to predict their occurrence or how they will affect MeaTech. If one or more of the factors affecting MeaTech's forward-looking information and statements proves incorrect, then MeaTech's actual results, performance or achievements could differ materially from those expressed in, or implied by, forward-looking information and statements contained in this press release. Therefore, MeaTech cautions you not to place undue reliance on its forward-looking information and statements. MeaTech disclaims any duty to revise or update the forward-looking statements, whether written or oral, to reflect actual results or changes in the factors affecting the forward-looking statements, except as specifically required by law. 

     

    MeaTech Press Contact: 

      

    MeaTech Investor Contacts: 

      

    Maissa Dauriac 

    Rainier Communications 

    [email protected] 

     

    Joseph Green 

    Edison Group  

    [email protected] 

      

    Ehud Helft 

    Edison Israel  

    [email protected] 

     









     

     

    Cision View original content:https://www.prnewswire.com/news-releases/meatech-reports-financial-results-for-q1-2022-and-provides-business-update-301557754.html

    SOURCE MeaTech 3D Ltd.

    Get the next $MITC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MITC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MITC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Steakholder Foods™ Reports Financial Results for Q2 2022 and Provides Business Update

    The company continued to develop the technology, R&D and marketing infrastructure necessary to accelerate toward commercialization of cultured meat REHOVOT, Israel, Aug. 24, 2022 /PRNewswire/ --  Steakholder Foods (NASDAQ:STKH), formerly MeaTech 3D Ltd. (NASDAQ:MITC), an international deep-tech food company at the forefront of the cultured meat industry, today released its financial results for Q2 2022 and provided a business update. Steakholder Foods is developing high quality beef, chicken, pork, and seafood products made from animal cells rather than farm-raised animals — as whole cuts, ground and raw materials — that are safer and with significantly less impact than conventional meat.   

    8/24/22 7:00:00 AM ET
    $STKH
    $MITC
    Packaged Foods
    Consumer Staples

    Cultured Meat Company MeaTech 3D Becomes Steakholder™ Foods

    The new name reflects the company's commitment to cultivating a new community of meat lovers who will participate in the company's mission to make high-quality real meat sustainably REHOVOT, Israel, Aug. 3, 2022 /PRNewswire/ -- MeaTech 3D Ltd. (NASDAQ:MITC), an international deep-tech food company at the forefront of the cultured meat industry, has become Steakholder™ Foods Ltd. (NASDAQ:STKH). Beginning in 2019, the company set out to develop the technology and scientific processes to produce whole cuts of meat sustainably using animal cell cultivation and 3D bioprinting. Stea

    8/3/22 8:00:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples

    MeaTech 3D Announces Collaboration with Umami Meats, a Singaporean Cultured Seafood Company

    The collaboration creates an opportunity to penetrate the Asian market with 3D-bioprinted structured seafood products REHOVOT, Israel, July 12, 2022 /PRNewswire/ -- MeaTech 3D Ltd. (NASDAQ:MITC) ("MeaTech"), an international deep-tech food company at the forefront of the cultured meat industry, is pleased to announce that it has signed a memorandum of understanding with Umami Meats for the joint development of 3D-printed cultured structured seafood.     Umami Meats is a Singapore-based cultured seafood company with a focus on developing species that are expected to experience severe supply-side shortages in the coming years due to climate change, overfishing and continuously growing consume

    7/12/22 7:40:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples

    $MITC
    SEC Filings

    View All

    SEC Form 6-K filed by MeaTech 3D Ltd.

    6-K - Steakholder Foods Ltd. (0001828098) (Filer)

    1/23/23 6:01:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples

    SEC Form 6-K filed by MeaTech 3D Ltd.

    6-K - Steakholder Foods Ltd. (0001828098) (Filer)

    1/11/23 4:02:49 PM ET
    $MITC
    Packaged Foods
    Consumer Staples

    SEC Form 6-K filed by MeaTech 3D Ltd.

    6-K - Steakholder Foods Ltd. (0001828098) (Filer)

    1/10/23 4:13:15 PM ET
    $MITC
    Packaged Foods
    Consumer Staples

    $MITC
    Leadership Updates

    Live Leadership Updates

    View All

    MeaTech 3D Announces Leadership Changes to Better Focus on Achieving Current Strategic Objectives

    NESS ZIONA, Israel, Jan. 25, 2022 /PRNewswire/ -- MeaTech 3D Ltd. (NASDAQ:MITC) announced today the following changes to its executive management team and Board of Directors: Mr. Sharon Fima announced that, in light of the Company's current stage of development, he intends to step down from the positions of Chief Executive Officer, Chief Technology Officer and Director in the near future. Mr. Fima intends to continue supporting the Company as a founding member of the Company's scientific advisory board. Mr. Fima: "As a co-founder of MeaTech, it has been my passion and my privilege to lead the Company through its formative years of real cultivated meat development, and at this stage of the C

    1/25/22 9:25:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples

    $MITC
    Financials

    Live finance-specific insights

    View All

    MeaTech 3D Schedules 2021 Results Release & Conference Call for Thursday, March 24, 2022

    REHOVOT, Israel, March 15, 2022 /PRNewswire/ -- MeaTech 3D Ltd. (NASDAQ:MITC) announced that it will release its financial results for 2021 on Thursday, March 24, 2022. The company will host a conference call on the same day, starting at 8:30 am (EDT). Management will host the call and be available to answer questions after providing a business update and presenting the results. To participate, please call one of the following telephone numbers a few minutes before the start of the call: US:                                   1-888-281-1167              8:30 am (Eastern Time)Israel:                               03-918-0609                   2:30 pm (Israel Time)International:               

    3/15/22 7:00:00 AM ET
    $MITC
    Packaged Foods
    Consumer Staples

    $MITC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by MeaTech 3D Ltd.

    SC 13D - Steakholder Foods Ltd. (0001828098) (Subject)

    9/22/22 7:09:25 AM ET
    $MITC
    Packaged Foods
    Consumer Staples